Bryce Point Capital’s CME Group CME Stock Holding History

Bryce Point Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,346	Closed	-$545K	–	234
2024 Q4	$545K	Buy	+2,346	New	+$539K	0.16%	204

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bryce Point Capital's CME Position: Q1 2025 in Review

Bryce Point Capital sold out of CME Group (CME) in Q1 2025, closing a stake of 2,346 shares — an estimated $545K sold.

Bryce Point Capital first reported a position in CME in Q4 2024 and held it in 1 quarter. The position peaked at $545K in Q4 2024. 1,596 funds tracked by Wall St. Rank hold CME as of Q1 2025.

Bryce Point Capital reported no remaining CME Group position as of Q1 2025 after selling out during the quarter.
Bryce Point Capital sold 2,346 CME Group shares in Q1 2025, an estimated $545K.
Bryce Point Capital first reported a position in CME Group in Q4 2024 and held it in 1 quarter.
Bryce Point Capital's CME Group position peaked at $545K in Q4 2024.
1,596 funds tracked by Wall St. Rank held CME Group as of Q1 2025.

Based on Bryce Point Capital's 13F filing for Q1 2025, filed 7 May 2025.